Shanghai Qilu Pharmaceutical Research and Development Center LTD
Shanghai Qilu Pharmaceutical Research and Development Center LTD
Explore linked clinical trials.4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of QLS2312 Injection | Healthy Participants Study | Not yet recruiting | Phase 1 | 2026-10-06 | NCT07861581 | |
| Phase I Study of QLS1510 Tablets in Healthy Participants | Digestive System Diseases, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder | Not yet recruiting | Phase 1 | 2026-08-12 | NCT07760077 | |
| This Study Aims to Evaluate the Efficacy and Safety of QLS1317 in Patients With MSI-H/dMMR Advanced Solid Tumors. | MSI-H or dMMR Advanced Solid Tumors | Not yet recruiting | Phase 1 | 2026-04-27 | NCT07552376 | |
| A Phase I Study of QLS12010 Capsules: Safety, Tolerability, PK, PD, and Food Effects in Healthy Adults and Moderate to Severe Atopic Dermatitis Patients | Bacterial Infections and Mycoses, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypersensitivity, Immediate, Infections, Skin Diseases, Eczematous, Skin and Connective Tissue Diseases, Suppuration, arthritic joint disease, arthropathy, atopic eczema, autoimmune disease, bacterial infectious disease, connective tissue disorder, dermatitis, hereditary disease, hereditary skin disorder, hidradenitis, hidradenitis suppurativa, immune system disorder, musculoskeletal system disorder, rheumatic disorder, rheumatoid arthritis, skin disease caused by bacterial infection, skin disorder, skin disorder caused by infection, sweat gland disorder | Recruiting | Phase 1 | 2025-07-31 | NCT06946641 |